MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2020

    Creating National Competencies in Physical Activity for Exercise Professionals Working with People with Parkinson’s Disease

    L. Hoffman, M. Rafferty (New York, NY, USA)

    Objective: On March 5-6th 2020, the Parkinson’s Foundation is convening a meeting to assemble thought leaders in physical activity and education for Parkinson’s disease.  Our…
  • MDS Virtual Congress 2020

    Movement disorders and it association with immunological causes: the key is in the movement

    E.M Gatto, G. Da Prat, J.L Etcheverry, M.E Cesarini, N. Gonzalez Rojas (CABA, Argentina)

    Objective: Observe the clinical and biochemical characteristics and the result of the treatment instituted in movement immune-mediated etiology. Background: Paraneoplastic autoimmune movement disorders are a…
  • MDS Virtual Congress 2020

    Emerging motor dysfunction in those at-risk of Parkinson’s disease: 5-year follow-up of PREDICT-PD participants

    C. Simonet, A. Schrag, J. Bestwick, A. Lees, A. Noyce (London, United Kingdom)

    Objective: To determine how motor features emerge over time in individuals estimated to be at higher risk of Parkinson’s disease (PD), compared with lower risk…
  • MDS Virtual Congress 2020

    Advance Care Planning in Complex Stage Parkinson’s Disease

    M. Khwaja, A. Chatterjee, H. Avery, C. James (Reading, United Kingdom)

    Objective: Advance Care Planning (ACP) in patients with Complex stage Parkinson’s disease (PD) at the Royal Berkshire Foundation Trust (RBFT),Reading,United Kingdom. Background: In April 2019,…
  • MDS Virtual Congress 2020

    Role of Sex in Parkinson’s Disease Progression

    E. Bayram, S. Eberly, D. Oakes, I. Litvan (La Jolla, CA, USA)

    Objective: To investigate the sex differences for disease progression in Parkinson’s disease (PD). Background: Prevalence and symptom profile in PD differ between women and men.…
  • MDS Virtual Congress 2020

    Correlation of brain activity measured using quantitative electroencephalography and cognitive function in patients with de novo Parkinson’s disease

    Y.S Kim, S.M Kim, H.W Shin, Y.C Youn, S.W Kang (Seoul, Republic of Korea)

    Objective: We performed an exploratory analysis of the correlation of brain activity measured using qEEG and early cognitive function in patients with de novo PD.…
  • MDS Virtual Congress 2020

    Does age at onset of Parkinson’s disease affect the development of dementia?

    P. Soliveri, F. Del Sorbo, A. Zecchinelli, G. Sacilotto, N. Meucci, M. Zini, C. Mariani, S. Tesei, G. Pezzoli (Milan, Italy)

    Objective: To investigate whether progression to dementia in senile Parkinson’s disease, SPD, (disease onset after 70 years) differs from that in old Parkinson’s disease, OPD,…
  • MDS Virtual Congress 2020

    A Fluctuating Qualitative Dermatoglyphic Trait, Dankmeijer’s and Furuhata’s Index as a Risk Marker in Diabetic Parkinson’s Patients of Guyana: A Case-Control Study

    A. Jha, S. D'costa, W. White, M. Chapp, D. Kanhai (Managua, Nicaragua)

    Objective: The current study aims to compare and evaluate the fluctuating qualitative dermatoglyphic trait, Furuhata’s and Dankmeijer’s index as a risk marker in Diabetes and…
  • MDS Virtual Congress 2020

    Identification of Parkinson’s disease predisposition genes in high-risk pedigrees

    P. Moretti, K. Figueroa, S. Pulst, L. Cannon-Albright (Salt Lake City, UT, USA)

    Objective: To identify families with an increased risk of Parkinson’s disease (PD) and the gene variants associated with such increased disease risk studying large multi-generation…
  • MDS Virtual Congress 2020

    Alpha-synuclein and Amyloid beta peptide 1-42 in Parkinson’s disease and parkinsonian plus syndrome cohorts

    G. Babu, M. Gupta, V. Paliwal (Lucknow, India)

    Objective: To evaluate the serum levels of α-synuclein (α-syn) and Amyloid β 1-42 (Aβ1-42) in the patients of Parkinson’s disease (PD), progressive supranuclear palsy (PSP)…
  • « Previous Page
  • 1
  • …
  • 58
  • 59
  • 60
  • 61
  • 62
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley